Brainstorm Cell Therapeutics reported $15.15M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Adamis Pharmaceuticals ADMP:US 17.77M 5.45M
Biogen BIIB:US $ 1749.3M 512.1M
Brainstorm Cell Therapeutics BCLI:US $ 15.15M 3.7M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Cytokinetics CYTK:US $ 115.42M 2.76M
Gilead Sciences GILD:US $ 4296M 1042M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Idera Pharmaceuticals IDRA:US $ 27.99M 4.55M